AXELIFE

AXELIFE is a French Medtech company dedicated to assessing and preventing cardiovascular risks through innovative medical technology. They design and manufacture advanced diagnostic solutions that focus on measuring arterial stiffness, an important indicator of cardiovascular health. Their main product, the pOpmètre®, is a Class IIa medical device that non-invasively measures pulse wave velocity (PWV), recognized as the gold standard for assessing arterial stiffness. The device provides quick and reliable cardiovascular risk assessments in under two minutes, requiring minimal training for use. It also calculates related parameters like the ankle-brachial index and central blood pressures, offering a comprehensive view of vascular health. The pOpmètre® features a clear output called vascular age, which helps patients understand their cardiovascular risk and encourages lifestyle changes. AXELIFE's technology is backed by a strong scientific foundation, with contributions to over 30 publications validating the clinical value of arterial stiffness measurement. The company is ISO 13485 certified and holds the CE 1282 mark, ensuring compliance with medical device quality standards in Europe. AXELIFE primarily serves healthcare providers, including general practitioners and cardiologists, aiming to enhance cardiovascular prevention through accessible and validated tools.

• Employees 5
• Founded 2010